Visceral leishmaniasis concurrent with splenic marginal zone B-cell lymphoma
- Authors: Julhakyan UL1, Magomedova AU1, Dvirnyk VN1, Kravchenko SK1
-
Affiliations:
- «Гематологический научный центр» Министерства здравоохранения Российской Федерации
- Issue: Vol 88, No 2 (2016)
- Pages: 78-80
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/31931
- ID: 31931
Cite item
Full Text
Abstract
Splenic marginal zone B-cell lymphoma (SMZBCL) is a rare non-Hodgkin B-cell lymphoma that presents with morphologically mature lymphoid cells corresponding in their immunological characteristics to secondary follicular marginal zone lymphocytes. It is clinically characterized by splenomegaly, moderate lymphocytosis, usually focal bone marrow lesion, sometimes moderate of monoclonal immunoglobulin in the serum (generally IgM or IgG) and/or urea, and a relatively benign course. Leishmaniasis is a transmissible natural focal infectious endemic disease that has a great diversity of clinical manifestations. The authors describe Russia’s first case of SMZBCL concurrent with visceral leishmaniasis in a 52-year-old female patient admitted to a hematology hospital with weakness, splenomegaly, and lymphadenopathy. The simultaneous detection of lymphoma and leishmaniasis in the same biopsy specimen is extremely rare. Visceral leishmaniasis should be borne in mind as an opportunistic infection in patients with malignancies, particularly in immunocompromised persons who live or have stayed in the endemic areas.
About the authors
U L Julhakyan
«Гематологический научный центр» Министерства здравоохранения Российской ФедерацииМосква, Россия
A U Magomedova
«Гематологический научный центр» Министерства здравоохранения Российской ФедерацииМосква, Россия
V N Dvirnyk
«Гематологический научный центр» Министерства здравоохранения Российской ФедерацииМосква, Россия
S K Kravchenko
«Гематологический научный центр» Министерства здравоохранения Российской ФедерацииМосква, Россия
References
- Гериатрическая гематология. Заболевания системы крови в старших возрастных группах. Под ред. Гриншпун Л.Д., Пивника А.В. М.: Медиум; 2012.
- Джулакян У.Л., Обухова Т.Н., Капланская И.Б. Лимфоцитома селезенки с перестройкой локуса гена BCL-6/3q27. Гематология и трансфузиология. 2009;54(3):48-52.
- Силаев М.А., Карагюлян С.Р., Буланов А.Ю., Джулакян У.Л., Егорова Е.К., Магомедова А.У., Капланская И.Б., Пантелеев И.В. Спленэктомия при массивной и гигантской спленомегалии. Гематология и трансфузиология. 2011;56(1): 6-10.
- Isaacson PG, Piris MA. Splenic marginal zone lymphoma. Advances in Anatomic Pathology. 1997;4:191-201.
- Julhakyan U, Magomedova A, Kravchenko S, Moiseeva T, Karagulyan S, Savenko T, Samoylova R, Kaplanskaya I, Obukhova T, Gemjyan E, Vorobjev A. Splenic marginal zone lymphoma: characteristics and treatment. Haematologica. 2011;96(Suppl 2): 393-394.
- Piscopo TV, Mallia Azzopardi C. Leishmaniasis. Postgraduate Med J. 2006;82:649-657. doi: 10.1136/pgmj.2006.047340corr1.
- Понировский Е.Н., Стрелкова М.В., Гончаров Д.Б., Жиренкина Е.Н., Черникова Ю.А. Висцеральный лейшманиоз в странах содружества независимых государств (СНГ): итоги и основные направления дальнейшего изучения. Медицинская паразитология и паразитарные болезни. 2006;4:25-31.
- Nadeem M. Mantle Cell Lymphoma with Leishmaniasis: A Rare Association. J Rawalpindi Medical College. 2013;17(1):150-152.
- Domingues M, Menezes Y, Ostronoff F, Calixto R, Florencio R, Sucupira A, Souto-Maior AP, Ostronoff M. Coexistence of Leishmaniasis and Hodgkin’s Lymphoma in a Lymph Node. J Clin Oncol. 2009;27(32):e184-e185.
- Toogeh G, Shirkoohi R, Keyhani M, Nickbin N, Najafi S, Salimi M, Farsi L, Ferdowsi S. Visceral Leishmaniasis Presented as Myelofibrosis and Low grade lymphoma in a Sporadic Region of Iran, Report a Rare Case. Int J Hematol-Oncol Stem Cell Res. 2010;4(3):36-39.
- Madariaga M, Kohl S, Starlin R, Smith Ph, West W. Visceral Leishmaniasis in an HIV-infected Patient. Infect Dis Clin Pract. 2006;14(2):199-122.
- Fakhar M, Asgari Q, Motazedian MH, Monabati A. Mediterranean visceral leishmaniasis associated with acute lymphoblastic leukemia (ALL). Parasitol Res. 2008;103:473-475.
- Kumar R, Daga M, Kamble N, Sothwal A, Singh T, Nayak H, Raizada R. Rare association of Visceral leishmaniasis with Hodgkin’s disease: A case report. Infectious Agents and Cancer. 2011;6(17):1-3. doi: 10.1186/1750-9378-6-17.
- Kopterides P, Mourtzoukou EG, Skopelitis E, Tsavaris N, Falagas ME. Aspects of the association between leishmaniasis and malignant disorders. Transactions of Royal Society of Tropical Medicine and Hygiene. 2007;101:1181-1189. doi: 10.1016/j.trstmh.2007.08.003.
- Albrecht H, Sobottka I, Emminger C, Jablonowski H, Just G, Stoehr A, Kubin T, Salzberger B, Lutz T, van Lunzen J. Visceral leishmaniasis emerging as an important opportunistic infection in HIV-infected persons living in areas nonendemic for Leishmania donovani. Arch Pathol Lab Medicine. 1996;120:189-198.
- Fernandez-Guerrero ML, Aguado JM, Buzon L, Barros C, Montalban C, Martin T, Bouza E. Visceral leishmaniasis in immunocompromised hosts. Am J Med. 1987;83:1098-1102. doi: 10.1016/0002-9343(87)90948-x.
- Dereure J, Duong Thanh H, Lavabre-Bertrand T, Cartron G, Bastides F, Richard-Lenoble D, Dedet JP. Visceral leishmaniasis: Persistence of parasites in lymph nodes after clinical cure. J Infect. 2003;47:77-81. doi: 10.1016/s0163-4453(03)00002-1.
- Kaae J, Nørgaard P, Himmelstrup B. Visceral leishmaniasis diagnosed in a patient with MALT lymphoma. Eur J Intern Med. 2007;18:235-237. doi: 10.1016/j.ejim.2006.09.033.
- Boutros N, Hawkins D, Nelson M, Lampert IA, Naresh KN. Burkitt lymphoma and leishmaniasis in the same tissue sample in an AIDS patient. Histopathology. 2006;48:880-881. doi: 10.1111/j.1365-2559.2006.02434.x.
- Felipe Suarez F, Lortholary O, Hermine O, Lecuit M. Infection-associated lymphomas derived from marginal zone B cells: a model of antigen-driven lymphoproliferation. Blood. 2006;107(8): 3034-3044. doi: 10.1182/blood-2005-09-3679.
- Джулакян У.Л. Вирусные гепатиты и лимфома из клеток маргинальной зоны селезенки: подходы к терапии. Клиническая онкогематология. 2012;6(1):120-123.
![](/img/style/loading.gif)